Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-6,746
Closed -$232K 516
2017
Q4
$232K Hold
6,746
0.02% 548
2017
Q3
$228K Sell
6,746
-15,388
-70% -$495K 0.02% 527
2017
Q2
$705K Sell
22,134
-493,694
-96% -$15.6M 0.03% 464
2017
Q1
$16.7M Sell
515,828
-205,108
-28% -$6.47M 0.12% 109
2016
Q4
$22.2M Sell
720,936
-65,348
-8% -$1.99M 0.1% 156
2016
Q3
$25.3M Sell
786,284
-58,075
-7% -$1.94M 0.12% 136
2016
Q2
$28.2M Sell
844,359
-285,634
-25% -$9.12M 0.13% 131
2016
Q1
$31.8M Buy
1,129,993
+169,377
+18% +$4.84M 0.15% 100
2015
Q4
$29.4M Sell
960,616
-349,401
-27% -$11M 0.14% 103
2015
Q3
$39M Sell
1,310,017
-321,364
-20% -$10.3M 0.16% 113
2015
Q2
$51.9M Buy
1,631,381
+299,757
+23% +$9.77M 0.23% 63
2015
Q1
$44M Buy
1,331,624
+342,972
+35% +$10.9M 0.2% 87
2014
Q4
$29.2M Sell
988,652
-238,942
-19% -$6.85M 0.12% 137
2014
Q3
$34.4M Sell
1,227,594
-555,774
-31% -$15.6M 0.14% 97
2014
Q2
$50.2M Buy
1,783,368
+248,955
+16% +$7.1M 0.23% 43
2014
Q1
$46.8M Buy
1,534,413
+294,593
+24% +$8.78M 0.2% 68
2013
Q4
$36M Sell
1,239,820
-396,410
-24% -$11.5M 0.13% 105
2013
Q3
$44.6M Sell
1,636,230
-311,562
-16% -$8.48M 0.16% 86
2013
Q2
$51.8M Buy
+1,947,792
New +$53.8M 0.19% 66

Other funds holding PFE

Timber Hill's PFE Position: Q4 2018 in Review

Timber Hill sold out of Pfizer (PFE) in Q4 2018, closing a stake of 67,076 shares — an estimated $2.81M sold.

Timber Hill first reported a position in PFE in Q4 2013 and held it in 10 quarters. The position peaked at $8.02M in Q3 2014. 2,403 funds tracked by Wall St. Rank hold PFE as of Q4 2018.

  • Timber Hill reported no remaining Pfizer position as of Q4 2018 after selling out during the quarter.
  • Timber Hill sold 67,076 Pfizer shares in Q4 2018, an estimated $2.81M.
  • Timber Hill first reported a position in Pfizer in Q4 2013 and held it in 10 quarters.
  • Timber Hill's Pfizer position peaked at $8.02M in Q3 2014.
  • 2,403 funds tracked by Wall St. Rank held Pfizer as of Q4 2018.

Based on Timber Hill's 13F filing for Q4 2018, filed 11 Feb 2019.